Nobuko Koshikawa
Chiba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Downregulation of sST2, a decoy receptor for interleukin-33, enhances subcutaneous tumor growth in murine pancreatic cancer cells.
Journal: FEBS open bio
Published: March 05, 2025
ATR Inhibition Synergizes With Alkylating PI Polyamide Targeting MYCN by Suppressing DNA Repair in MYCN-Amplified Neuroblastoma.
Journal: Cancer science
Published: December 09, 2024
Poly (ADP-ribose) polymerase inhibitor sensitized DNA damage caused by an alkylating pyrrole-imidazole polyamide targeting MYCN in neuroblastoma cells.
Journal: Biochemical and biophysical research communications
Published: August 09, 2024
Hypoxia induces downregulation of the tumor-suppressive sST2 in colorectal cancer cells via the HIF-nuclear IL-33-GATA3 pathway.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 24, 2023
Use of DNA-alkylating pyrrole-imidazole polyamides for anti-cancer drug sensitivity screening in pancreatic ductal adenocarcinoma.
Journal: Cancer medicine
Published: July 14, 2022
Anticancer effect of a pyrrole-imidazole polyamide-triphenylphosphonium conjugate selectively targeting a common mitochondrial DNA cancer risk variant in cervical cancer cells.
Journal: International journal of cancer
Published: April 20, 2022
Suppression of non-small-cell lung cancer A549 tumor growth by an mtDNA mutation-targeting pyrrole-imidazole polyamide-triphenylphosphonium and a senolytic drug.
Journal: Cancer science
Published: November 04, 2021
Mitochondria: Endosymbiont bacteria DNA sequence as a target against cancer.
Journal: Cancer science
Published: August 12, 2021
A linear five-ring pyrrole-imidazole polyamide-triphenylphosphonium conjugate targeting a mitochondrial DNA mutation efficiently induces apoptosis of HeLa cybrid cells carrying the mutation.
Journal: Biochemical and biophysical research communications
Published: August 04, 2021
Intercellular transfer of mitochondrial DNA carrying metastasis-enhancing pathogenic mutations from high- to low-metastatic tumor cells and stromal cells via extracellular vesicles.
Journal: BMC molecular and cell biology
Published: March 22, 2021
MCT4 is induced by metastasis-enhancing pathogenic mitochondrial NADH dehydrogenase gene mutations and can be a therapeutic target.
Journal: Scientific reports
Published: February 10, 2021
Last Updated: 09/26/2026